TrialThe Journal of dermatology2016

Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double-blind, phase 3 study.

Akihiko Asahina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.